Most cited papers in Ferroptosis and cancer prognosis
What are the most cited papers in Ferroptosis and cancer prognosis?
The most cited paper in Ferroptosis and cancer prognosis is "Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death" (Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al., 2012), with 19,018 citations. Next come "Inferring tumour purity and stromal and immune cell admixture from expression data" (10,966) and "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease" (7,867).
Showing 50 of 100 papers. Every paper with more than 1,196 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell | May 2012 | 19,018 |
| 2 | Inferring tumour purity and stromal and immune cell admixture from expression data Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · Nature Communications | 11 Oct 2013 | 10,966 |
| 3 | Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease Brent R. Stockwell et al. · Cell | Oct 2017 | 7,867 |
| 4 | Regulation of Ferroptotic Cancer Cell Death by GPX4 Wan Seok Yang, Rohitha Sriramaratnam, Matthew Welsch et al. · Cell | 2014 | 7,814 |
| 5 | Ferroptosis: mechanisms, biology and role in disease Xuejun Jiang, Brent R. Stockwell, Marcus Conrad · Nature Reviews Molecular Cell Biology | 25 Jan 2021 | 7,650 |
| 6 | UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses Darshan Shimoga Chandrashekar, Bhuwan Bashel, Sai Akshaya Hodigere Balasubramanya et al. · Neoplasia | 18 Jul 2017 | 6,610 |
| 7 | The Immune Landscape of Cancer Vésteinn Thórsson et al. · Immunity | Apr 2018 | 6,328 |
| 8 | Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine | 25 Sep 2015 | 5,972 |
| 9 | TIMER2.0 for analysis of tumor-infiltrating immune cells Taiwen Li, Jingxin Fu, Zexian Zeng et al. · Nucleic Acids Research | 17 May 2020 | 5,803 |
| 10 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Robert John Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine | 10 Jan 2007 | 5,801 |
| 11 | Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response Peng Jiang, Shengqing Stan Gu, Deng Pan et al. · Nature Medicine | 13 Aug 2018 | 5,708 |
| 12 | The consensus molecular subtypes of colorectal cancer Justin Guinney et al. · Nature Medicine | 12 Oct 2015 | 5,415 |
| 13 | Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine | 21 Mar 2018 | 4,756 |
| 14 | TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data Antonio Colaprico, Tiago C. Silva, Catharina Olsen et al. · Nucleic Acids Research | 23 Dec 2015 | 4,660 |
| 15 | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Anthony B. El-Khoueiry et al. · The Lancet | 20 Apr 2017 | 4,384 |
| 16 | Ferroptosis: molecular mechanisms and health implications Daolin Tang, Xin Chen, Rui Kang et al. · Cell Research | 2 Dec 2020 | 4,365 |
| 17 | ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition Sebastian G. Doll et al. · Nature Chemical Biology | 14 Nov 2016 | 4,302 |
| 18 | Ferroptosis: past, present and future Jie Li, Feng Cao, He-liang Yin et al. · Cell Death and Disease | 3 Feb 2020 | 4,259 |
| 19 | Ferroptosis: process and function Yang Xie, Wen‐Chi Hou, Xinxin Song et al. · Cell Death and Differentiation | 22 Jan 2016 | 3,847 |
| 20 | Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden Zachary Rockow Chalmers et al. · Genome Medicine | 13 Apr 2017 | 3,800 |
| 21 | Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice José Pedro Friedmann Angeli et al. · Nature Cell Biology | 17 Nov 2014 | 3,780 |
| 22 | The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis Kirill Bersuker, Joseph M. Hendricks, Zhipeng Li et al. · Nature | 21 Oct 2019 | 3,764 |
| 23 | Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge Katarzyna J. Tomczak, Patrycja Czerwińska, Maciej Wiznerowicz · Współczesna Onkologia | 2015 | 3,596 |
| 24 | Ferroptosis as a p53-mediated activity during tumour suppression Le Jiang, Ning Kon, Tongyuan Li et al. · Nature | 18 Mar 2015 | 3,475 |
| 25 | Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine | 17 Feb 2017 | 3,457 |
| 26 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Francisco Sánchez-Vega et al. · Cell | Apr 2018 | 3,452 |
| 27 | FSP1 is a glutathione-independent ferroptosis suppressor Sebastian G. Doll et al. · Nature | 21 Oct 2019 | 3,394 |
| 28 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression Chih‐Hao Chang, Jing Qiu, David O’Sullivan et al. · Cell | 27 Aug 2015 | 3,388 |
| 29 | The prognostic landscape of genes and infiltrating immune cells across human cancers Andrew J. Gentles, Aaron M. Newman, Chih Long Liu et al. · Nature Medicine | 20 Jul 2015 | 3,329 |
| 30 | Ferroptosis: Death by Lipid Peroxidation Wan Seok Yang, Brent R. Stockwell · Trends in Cell Biology | 2 Dec 2015 | 3,183 |
| 31 | Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications Brent R. Stockwell · Cell | Jul 2022 | 3,121 |
| 32 | Comprehensive molecular characterization of urothelial bladder carcinoma John N. Weinstein et al. · Nature | 28 Jan 2014 | 3,110 |
| 33 | Broadening horizons: the role of ferroptosis in cancer Xin Chen, Rui Kang, Guido Kroemer et al. · Nature Reviews Clinical Oncology | 29 Jan 2021 | 3,006 |
| 34 | Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis Valerian E. Kagan et al. · Nature Chemical Biology | 14 Nov 2016 | 2,996 |
| 35 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Weimin Wang et al. · Nature | May 2019 | 2,952 |
| 36 | TISIDB: an integrated repository portal for tumor–immune system interactions Beibei Ru, Ching Ngar Wong, Yin Tong et al. · Bioinformatics | 20 Mar 2019 | 2,668 |
| 37 | UALCAN: An update to the integrated cancer data analysis platform Darshan Shimoga Chandrashekar, Santhosh Kumar Karthikeyan, Praveen Kumar Korla et al. · Neoplasia | 22 Jan 2022 | 2,635 |
| 38 | Targeting Ferroptosis to Iron Out Cancer Behrouz Hassannia, Peter Vandenabeele, Tom Vanden Berghe · Cancer Cell | 16 May 2019 | 2,629 |
| 39 | LinkedOmics: analyzing multi-omics data within and across 32 cancer types Suhas V. Vasaikar, Péter Straub, Jing Wang et al. · Nucleic Acids Research | 26 Oct 2017 | 2,601 |
| 40 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer A. Gordon Robertson et al. · Cell | Oct 2017 | 2,556 |
| 41 | Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy Pranavi Koppula, Li Zhuang, Boyi Gan · Protein & Cell | 30 Sep 2020 | 2,550 |
| 42 | NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis Matthew B. Dodson, Raúl Castro-Portuguez, Donna D. Zhang · Redox Biology | 11 Jan 2019 | 2,486 |
| 43 | The role of iron and reactive oxygen species in cell death Scott J. Dixon, Brent R. Stockwell · Nature Chemical Biology | 17 Dec 2013 | 2,410 |
| 44 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Tathiane Maistro Malta et al. · Cell | Apr 2018 | 2,396 |
| 45 | Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis Wan Seok Yang, Katherine J. Kim, Michael M. Gaschler et al. · Proceedings of the National Academy of Sciences | 9 Aug 2016 | 2,348 |
| 46 | Malignant astrocytic glioma: genetics, biology, and paths to treatment Frank B. Furnari, Tim R. Fenton, Robert M. Bachoo et al. · Genes & Development | Nov 2007 | 2,335 |
| 47 | Autophagy promotes ferroptosis by degradation of ferritin Wen‐Chi Hou, Yangchun Xie, Xinxin Song et al. · Autophagy | 31 May 2016 | 2,332 |
| 48 | Targeting ferroptosis as a vulnerability in cancer Guang Lei, Li Zhuang, Boyi Gan · Nature reviews. Cancer | 25 Mar 2022 | 2,268 |
| 49 | Ferroptosis as a target for protection against cardiomyopathy Xuexian Fang, Hao Wang, Dan Han et al. · Proceedings of the National Academy of Sciences | 28 Jan 2019 | 2,204 |
| 50 | Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma Robert John Motzer, Thomas E. Hutson, Piotr Tomczak et al. · Journal of Clinical Oncology | Jun 2009 | 2,196 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.